期刊文献+

204例肝移植受者服药依从性单中心分析 被引量:13

A single center analysis of medication compliance in 204 liver transplant recipients
下载PDF
导出
摘要 目的对肝移植受者的服药依从性现状进行调查,并分析其影响因素。方法采用受者一般资料调查表和《Morisky服药依从性量表》对肝移植受者进行问卷调查。结果 204例肝移植受者中,依从性低者52例(25.5%),依从性中等者105例(51.5%),依从性高者47例(23%),其中,婚姻状况、每日服药种类及药物了解程度等因素,对肝移植受者的服药依从性有影响(P <0.05)。结论肝移植受者的服药依从性仍有待提高,除加强受者自身对药物的重视程度之外,定期随访和必要的医疗干预将是受者获得长期存活的关键。 Objective To investigate the current status of medication compliance and analyze its influencing factors in liver transplant recipients.Methods A questionnaire survey was conducted on the liver transplant recipients using the demographic information and Morisky Medication Compliance Scale.Results A total of 204 liver transplant recipients were enrolled in this study,52 cases(25.5%)of which were lower compliance,105 cases(51.5%)were moderate compliance and 47 cases(23%)were high compliance.Marital status,type of daily medication and the level of understanding in the medication were influencing factors in the medication compliance of the liver transplant recipients(P<0.05).Conclusion The medication compliance of liver transplant recipients remains to be improved.It is necessary to strengthen the recipient's own attention on the medicine.The regular follow-up and necessary medical intervention will be the key to long-term survival.
作者 宫月乔 付晓悦 郑桃花 孙文娟 臧运金 饶伟 Gong Yueqiao;Fu Xiaoyue;Zheng Taohua;Sun Wenjuan;Zang Yunjin;Rao Wei(Center of Organ Transplantation,The Affiliated Hospital of Qingdao University,Qingdao 266000,Shandong,China)
出处 《实用器官移植电子杂志》 2019年第2期90-94,共5页 Practical Journal of Organ Transplantation(Electronic Version)
关键词 肝移植 服药依从性 影响因素 Liver transplantation Medication compliance Influencing factors
  • 相关文献

参考文献7

二级参考文献36

  • 1米庆胜.免疫抑制剂FK506及其临床应用[J].国外医学(皮肤性病学分册),1994,20(4):203-206. 被引量:3
  • 2陈忠华.同种肝脏移植免疫特惠器官现象及其临床意义[J].中华肝脏病杂志,2005,13(3):221-221. 被引量:5
  • 3汪艳,孙悦波.肾移植后FK506的监测状况[J].临床医药实践,2005,14(6):406-407. 被引量:8
  • 4Swanda S, Suzuki G, Kawase Y, et al. Novel immunosuppressive agent, FK506 in vitro effects on the cloned T cell activation. J Immunol, 1987,139(6): 1791~ 1803.
  • 5Romero M, Garcia Monzon C, Clemente G, et al. Modulation of ICAM-1 tissue expression in patients with liver transplatation and acute rejection after glucocorticoid treatment. Transpl Int, 2003,13(Suppl1): 456 ~460.
  • 6Mc Cauley J, Tankaya S, Fung J, et al. The question of FK506 nephrotoxity after liver transplantation. Transpl Proc, 1991, 23:1444~1447.
  • 7王怡.肝移植术后患者不舒适的原因分析及护理对策[J].护士进修杂志,2007,22(17):1620-1621. 被引量:3
  • 8汤钊猷.现代肿瘤学[M].上海:复旦大学出版社,2005:1-2.
  • 9Mazariegos GV,Reyes J,Marino J,et al.Risks and benefits of weaning immunousuppression in liver transplant recipients:long-termfollow-up[J].Transplant Proe,1997,29(12):1174.
  • 10Hirsh J, Fuster V,Ansell J,et al. American Heart As-sociation/ American College of Cardiology FoundationGuide to warfarin therapy [J]. Circulation,2003? 107(12):1692-1711.

共引文献321

同被引文献144

引证文献13

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部